Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves
NCT06476301
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Anticoagulation
Interventions
DRUG:
Rivaroxaban
Sponsor
RenJi Hospital